Member Info for countingcards

The price is the meantime has reacted very strongly in the positive. Was 1.3-1.6 at the time of the announcement, and now moving to 1.6-1.7p and buys are rolling in.

This part stands out for me:

-- Market launch and preparation for a clinical trial to support NHS and other global healthcare providers

Cizzle Biotechnology Holdings PLC Subscription, Facility & Publication of Prospectus
21/09/2022 11:23am
UK Regulatory (RNS & others)

Cizzle Biotechnology, the UK-based diagnostics developer, is pleased to announce that it has conditionally raised gross proceeds of GBP500,000 by way of the Subscription and secured a further GBP500,000 pursuant to the Facility in order to provide funds to progress the Group's strategy.

Highlights

-- Subscription to raise GBP500,000 through the issue of new Ordinary Shares at 1.5p per share ("Issue Price")

-- A further Facility of GBP500,000 is available to the Company, subject to Admission, to provide further funds, if required, repayable in shares at a fixed price of 1.8p per share

-- The funds raised will be used, inter alia, to provide working capital for the Company's strategy and to continue development of a laboratory-developed test ("LDT") accredited service for the early detection of lung cancer and taking the Company's proprietary CIZ1B biomarker blood test through to UKCA, CE marking and/or FDA 510(k) clearance

Use of proceeds

The proceeds of the Subscription, which are expected to total approximately GBP500,000 (before expenses of GBP40,000 excluding VAT), will be used to provide working capital for the Company and to fund the following:

-- Continued development of the test reagents, manufacture of test reagents, and validation of test configuration on patient samples

-- Development of a LDT certified test in accredited partner laboratories such as CorePath Laboratories, USA

-- Production of a UKCA, CE marked and/or FDA 510(k) cleared product, following successful validation on retrospective clinical sample sets and control cohorts

-- Market launch and preparation for a clinical trial to support NHS and other global healthcare providers

Nevada: Now this would be big. Only said that the other day to someone and glad you highlighted that as well.

Steve
Could you give a breakdown to what type of financing CIZ will need in your opinion?
What price the placing you believe will happen in your opinion later in the year and what the placing would be for?
What makes you think they will need financing?
You are not convinced that not too much money is coming in? Are you able to confirm your own findings?
If the directors were to buy what will that confirm to you? I know what it will confirm to me.
If the directors do not buy, are you aware of the reasons for that?
I am sure at some point you will read, and maybe reply. No rush.

(The above is based on all your previous and current posts on CIZ, over 30 days)

RNS Number : 3098Q

Cizzle Biotechnology Holdings PLC

27 June 2022

27 June 2022

Cizzle Biotechnology Holdings Plc

("Cizzle Biotechnology" or the "Company")

Result of AGM

Cizzle Biotechnology, the UK based diagnostics developer, announces that at the Annual General Meeting ("AGM") of the Company held earlier today, all resolutions were voted on by a poll and were passed.

*******************************************************************************************************

Decent buying coming through so hopefully the rerate is now happening.

Licker thanks for the reply mate. At this moment we really don't know what MM wants or is thinking and the danger is many investment decisions are made on emotional belief. He said one thing and it has been blown up out of proportion and exaggerated. The biggest danger is the herd mentality so obvious on here, and also the dirty mind games others are conveniently attempting to get weak holders to part with their shares. Patience, Patience and more Patience and that is not easy I accept, but in investing is vital. I don't know if MM wants to delist or remain, what we do know is that a couple of others have chanced their hand and been declined, and the stock volatiity due to that has moved from one group of short term holders to others who can read the situation.

I read yesterday "The only way you will die in the roller coaster ride is if you jump off! That applies here.

Yes licker you have missed something obvious. MM and co, are running a business that is trying to find the best solution to provide for the retail market, whether remaining on the market or private. We are just along for the ride, and once someone (not saying you) gets fixated on the shareprice, they either miss the opportunity to add in a growing business, or get desperate (not saying you) to cash in at the first opportunity. whether its £2.50 £3, or whatever. I am a customer of THG and really see the potential of D2C.

Customers are first priority otherwise THG is nothing.

BTW anyone again know why Form 8.5 are still being RNS'ed or am I directing my question to traders only here? (apologies if that is the case, I will try and find another route to my answer).

Commenting, Bill Behnke, Founder of The Behnke Group, said:

"I recently attended ASCO22, a major clinical sciences conference in Chicago, USA, where multiple meetings evidenced considerable interest in Cizzle Biotechnology's entry into the USA. Cizzle Biotechnology fits perfectly with the Behnke Group's mission to achieve better outcomes, lower costs and improve the health and safety of patients. We are excited to add Cizzle Biotechnology to our portfolio of game changing businesses."

REPEAT: "where multiple meetings evidenced considerable interest in Cizzle Biotechnology's entry into the USA. "

Looks like they have been busy in the USA. I understand there is a concern of about funding, but the forthcoming £1m from SGSC should be noted, plus I am sure there would be plenty of other suitors willing to fund the next stage without having to come to market?

Director buys now would mean currently nothing on the agenda and no close period. If no buys it should be seen as a positive, as there may be something still being worked in the background, and they don't want to be caught insider trading.

Secondly can anyone explain why we are still getting Form 8.5 RNS this morning? Even though both potential bids have been squashed. Is there still period of disclosure even after the confirmation from the two parties of pursuing? Or is there something relevant to Rule 2.8?

CIZ is now showing a lot of confidence in the price. Holding very well and threatening to go back above 2p at the least. As hard it has been for some, the price is a complete detachment from what is actually going on with the company. You can either moan at the drop or use it to add through price weakness, if reserves allow.

Never been more confident.

Absolutely agree given its whey protein concentrate (milk) 100% with none of the harmful additives others put in. 21g protein per 25g serving. As in a previous post I know a few who buy these in bulk and they are very satisfied. I can only see more sales down the line. Crazy as I am trying help someone gain weight, and made a deal I will supply a whole year's worth of MyProtein if this hits £2.50+ to them. As I have tried this myself I rate it better than most out there. Others are entitled to their opinions.

"People who lose money do so because they sell below the price they bought. Why? They pay attention to the share price & not the business. They get scared simply because the share price drops, ignorant of the business, it's valuation & potential valuation generation"

schalfenplanet, no one can give a time stamp my friend as to when the share price rises. However in its absence, one can either focus as the above paragraph states on the share price and get stressed OR focus on the area these guys are working within and realise its an issue which certainly as a business will urgently address namely lung cancer. For some this is still an opportunity, and the lower it goes and if funds available it becomes more of an opportunity. Totally with you on the point that if a share price is being manipulated, it means value or great expectations are expected. There is one in play right now.

So what you are saying in effect is that King Street who have Morgan Stanley working for them, have placed stooges on the BBs to play the system long and short, but especially short to get the price down to accumulate lower, all the while scaring the daylights out of weak holders who cannot make up their minds, or read, to exit? Once they have their fill they can realistically up the price to reasonable level above 170p all the while knowing it’s theirs as they now have the stock. All they have to do now is buy the shorts back to increase the holding further, or am I reading this wrong?
At the same time the danger to that scenario is that there are also other interest parties who will want to be making offers and will be accumulating, if they are serious, namely Candy ventures, or A.N.Other? This kind of puts a spanner in the works of the above first paragraph player, no? as it will kill their short positions.
So it makes sense why the price is bobbing between a range as we have a perfect storm of buyers and sellers pitting against each other right now.
You also have long term large holders from the IPO (Jupiter Fund Management) who will not just simply roll over and accept a large loss on their holding. They need to be appeased.
One thing is clear – a bid is odds on, but from where and what price it’s still early days. Personally cannot see it going for less than £2.50
On another personal note, I know people close who are buying the My protein range of foods and clothing like there is no tomorrow, and the special offers get snapped up quickly. That’s only in my own circle, then I think what would it be like across the earth?

From the Reuters article:
Aimee Donnellan she previously spent three years at The Sunday Times as banking correspondent.

Given the negative stance the ST have on THG not surprised with this article from an ex correspondent. They are doing their best to rubbish these potential bids. Anything to help the 'paymaster' They know their audience so fearmongering is not too difficult.

https://www.youtube.com/watch?v=AuvRgYfo-2s&ab_channel=XeniaTchoumi

would be helpful if I actually put the link in next time!

Believe Nick Candy sums up British Business Mentality V US in this video nicely. It can be seen clearly that instead of trying to build institutions on par with some US companys, instead the British media will bend to their paymasters (I will not mention their name, but they are rather a large Advertising giant who can swtich on and off the media budgets!) and burn down anyone trying to make a success, plus if they are not from within the inner circle city circle. Ther is no denying there has been an orchestrated attack on THG.

If you were a potential bidder you would be sweeping up as much as you can right now. The pattern of trading this morning is clearly being moved down from an initial top of 153p, in an organised manner to clear out the 10% traders, who seems happy to close out. All the while the potential bidder/s is sweeping up what is available and there is not much free float. If shorters are closing it only adds to the buying pressure for the bidder.
Once this area is completely cleaned out, the only way to gain further shares and voting rights, is to keep buying on the way up tempting the toughest of sellers.
The only thing to remember is we are on the verge of a weekend and even for the bidders there may be other bidders coming out of the woodwork over the weekend. It’s a storm brewing.
Bid 1: Candy Ventures Sarl ("Candy Ventures") confirms that it is in the very early stages of considering a possible offer for the entire issued AND TO BE ISSUED SHARE CAPITAL of the Company.
Bid 2: ?????
Bid 3: The Board of THG notes the recent press speculation and confirms that it received a THIRD unsolicited, highly preliminary and indicative non-binding proposal of 170 pence per share from Belerion Capital Group Limited ("Belerion"), together with King Street Capital Management, L.P. ("King Street") (collectively, the "Belerion Consortium") to acquire the entire issued and to be issued share capital of THG (the "Proposal").

So who is Bid 2?

Can anyone confirm?
I have Matthew Moulding on TIKR Terminal down as
13.60%
166,130,035
Date: 26.01.2022

However seen on Twitter (post from Toansy) that his holding is showing as:
14.98%
so based on the current total voting rights that would be 182,835,904.

That would be an increase of 16,805,869.

Some of the other holdings in that list alongside MM are identical or increased slightly. So on what figure has 14.98% been worked? as I had 13.60% asof 26.01.2022.

Goldman Sachs Asset Management Limited
Reported 20.01.2022
Shares held: 32,809,680
Total Voting Rights announced 03.05.2022: 1,221,200,967
Percentage holding: 2.6866%

Shares Held 05.11.2021 : 41185746
Shares Held 04.01.2022: 36497074